Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine ineffectiveness in hard-to-treat ADHD
NCT04167189Phase 1Completed
- Sponsor
- PhenoSolve
- Start
- Jan 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lidocaine 10% oropharyngeal spray, sponsored by PhenoSolve. Primary endpoint: Number of Participants With Lidocaine Ineffectiveness by Taste Test at Day 1. Started Jan 2018; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT04167189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167189.